IDR 2320.0
(-1.28%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 3.08 Billion IDR | -16.73% |
2022 | 3.7 Billion IDR | -71.58% |
2021 | 13.05 Billion IDR | -50.13% |
2020 | 26.16 Billion IDR | -40.72% |
2019 | 44.14 Billion IDR | 0.0% |
2018 | - IDR | 0.0% |
2017 | - IDR | -100.0% |
2016 | 41.67 Billion IDR | -71.12% |
2015 | 144.29 Billion IDR | 26.86% |
2014 | 113.74 Billion IDR | -5.58% |
2013 | 120.46 Billion IDR | 37.34% |
2012 | 87.7 Billion IDR | 204.13% |
2011 | 28.83 Billion IDR | 18.73% |
2010 | 24.29 Billion IDR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 237.72 Billion IDR | -52.55% |
2024 Q1 | 139.89 Billion IDR | 4428.95% |
2024 Q2 | 504.69 Billion IDR | 260.78% |
2023 Q2 | 403.49 Billion IDR | 10823.54% |
2023 Q1 | 3.69 Billion IDR | -0.42% |
2023 Q4 | 3.08 Billion IDR | -97.05% |
2023 FY | 3.08 Billion IDR | -16.73% |
2023 Q3 | 104.68 Billion IDR | -74.06% |
2022 Q3 | 3.9 Billion IDR | -80.46% |
2022 Q4 | 3.7 Billion IDR | -5.08% |
2022 FY | 3.7 Billion IDR | -71.58% |
2022 Q1 | 174.81 Billion IDR | 1239.54% |
2022 Q2 | 20 Billion IDR | -88.56% |
2021 Q2 | 114.86 Billion IDR | 593.91% |
2021 Q1 | 16.55 Billion IDR | -36.74% |
2021 Q4 | 13.05 Billion IDR | -82.56% |
2021 FY | 13.05 Billion IDR | -50.13% |
2021 Q3 | 74.8 Billion IDR | -34.87% |
2020 Q1 | 12.59 Billion IDR | -71.48% |
2020 Q3 | 32.43 Billion IDR | -63.17% |
2020 Q4 | 26.16 Billion IDR | -19.32% |
2020 FY | 26.16 Billion IDR | -40.72% |
2020 Q2 | 88.06 Billion IDR | 599.41% |
2019 Q3 | - IDR | -100.0% |
2019 FY | 44.14 Billion IDR | 0.0% |
2019 Q4 | 44.14 Billion IDR | 0.0% |
2019 Q2 | 47.01 Billion IDR | 0.0% |
2019 Q1 | - IDR | 0.0% |
2018 Q1 | 2.57 Billion IDR | 0.0% |
2018 Q2 | 47.81 Billion IDR | 1758.55% |
2018 Q3 | - IDR | -100.0% |
2018 FY | - IDR | 0.0% |
2018 Q4 | - IDR | 0.0% |
2017 Q3 | 87.86 Billion IDR | 9.61% |
2017 Q1 | 61.2 Billion IDR | 46.85% |
2017 Q2 | 80.16 Billion IDR | 30.98% |
2017 Q4 | - IDR | -100.0% |
2017 FY | - IDR | -100.0% |
2016 FY | 41.67 Billion IDR | -71.12% |
2016 Q2 | 105.99 Billion IDR | -39.4% |
2016 Q3 | 72.95 Billion IDR | -31.17% |
2016 Q4 | 41.67 Billion IDR | -42.87% |
2016 Q1 | 174.9 Billion IDR | 21.21% |
2015 Q3 | 185.69 Billion IDR | -1.55% |
2015 Q2 | 188.63 Billion IDR | 18.45% |
2015 Q1 | 159.24 Billion IDR | 40.01% |
2015 FY | 144.29 Billion IDR | 26.86% |
2015 Q4 | 144.29 Billion IDR | -22.3% |
2014 Q2 | 174.58 Billion IDR | 57.69% |
2014 Q4 | 113.74 Billion IDR | -26.11% |
2014 FY | 113.74 Billion IDR | -5.58% |
2014 Q3 | 153.93 Billion IDR | -11.83% |
2014 Q1 | 110.71 Billion IDR | -8.09% |
2013 FY | 120.46 Billion IDR | 37.34% |
2013 Q2 | 113.02 Billion IDR | 18.67% |
2013 Q1 | 95.24 Billion IDR | 8.59% |
2013 Q3 | 151.89 Billion IDR | 34.39% |
2013 Q4 | 120.46 Billion IDR | -20.7% |
2012 Q3 | - IDR | 0.0% |
2012 Q4 | 87.7 Billion IDR | 0.0% |
2012 FY | 87.7 Billion IDR | 204.13% |
2011 FY | 28.83 Billion IDR | 18.73% |
2010 FY | 24.29 Billion IDR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
PT Itama Ranoraya Tbk | 240.86 Billion IDR | 98.718% |
PT Kimia Farma (Persero) Tbk | 7926.98 Billion IDR | 99.961% |
PT Millennium Pharmacon International Tbk | 710.33 Billion IDR | 99.565% |
PT Soho Global Health Tbk | 19.94 Billion IDR | 84.515% |